Showing results (2371-2380 of 4,540) with videos related to

Sort By:
Pageof 454
Schizophrenia Bulletin|August 25, 2023
A Child-Parent Dyad Study on Adolescent Paranoia and the Influence of Adverse Life Events, Bullying, Parenting Stress, and Family SupportJessica L Kingston, Lyn Ellett, Elizabeth C Thompson, et al.
Schizophrenia Bulletin|August 22, 2023
Medical and Psychiatric Care Preceding the First Psychotic Disorder DiagnosisNicole M Benson, Zhiyou Yang, Vicki Fung, et al.
Schizophrenia Bulletin|August 22, 2023
Methodological Characteristics and Feasibility of Ecological Momentary Assessment Studies in Psychosis: a Systematic Review and Meta-AnalysisImogen H Bell, Emily Eisner, Stephanie Allan, et al.
Schizophrenia Bulletin|August 22, 2023
Longitudinal MicroRNA Signature of Conversion to PsychosisAnton Iftimovici, Qin He, Chuan Jiao, et al.
Schizophrenia Bulletin|August 22, 2023
Basal-Forebrain Cholinergic Nuclei Alterations are Associated With Medication and Cognitive Deficits Across the Schizophrenia SpectrumJulia Schulz, Felix Brandl, Michel J Grothe, et al.
Schizophrenia Bulletin|August 1, 2023
The Relevance of Animal Models of Social Isolation and Social Motivation for Understanding Schizophrenia: Review and Future DirectionsSusan B Powell, Neal R Swerdlow
Schizophrenia Bulletin|August 1, 2023
Predictors of Mortality Following a Schizophrenia Spectrum Diagnosis: Evidence From the 20-Year Follow-up of the OPUS Randomized Controlled TrialMarie Stefanie Kejser Starzer, Helene Gjervig Hansen, Carsten Hjorthøj, et al.
Schizophrenia Bulletin|July 19, 2023
Temporal Interactions Between Social Motivation and Behavior In Daily Life Among Individuals at Clinical High-Risk for PsychosisGregory P Strauss, Ian M Raugh, Lauren Luther, et al.
Schizophrenia Bulletin|July 19, 2023
Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI StudyElisa Rodríguez-Toscano, Clara Alloza, David Fraguas, et al.
Schizophrenia Bulletin|July 7, 2023
Mendelian Randomization Using the Druggable Genome Reveals Genetically Supported Drug Targets for Psychiatric DisordersXiaoyan Li, Aotian Shen, Yiran Zhao, et al.
Pageof 454